Although systemic inflammation and pulmonary complications increase the mortality rate in COVID-19, a broad spectrum of cardiovascular and neurological complications can also contribute to significant morbidity and mortality.

The molecular mechanisms underlying cardiovascular and neurological complications during and after SARS‐CoV‐2 infection are incompletely understood. Recently reported perturbations of the epitranscriptome of COVID-19 patients indicate that mechanisms including those derived from RNA modifications and non-coding RNAs may play a contributing role in the pathogenesis of COVID-19.

In this review paper, we gathered recently published studies investigating (epi)transcriptomic fluctuations upon SARS-CoV-2 infection, focusing on the brain-heart axis since neurological and cardiovascular events and their sequelae are of utmost prevalence and importance in this disease.

Cite as

Jusic, A., Stellos, K., Ferreira, L., Baker, A. & Devaux, Y. 2022, '(Epi)transcriptomics in cardiovascular and neurological complications of COVID-19', Journal of Molecular and Cellular Cardiology Plus, article no: 100013. https://doi.org/10.1016/j.jmccpl.2022.100013

Downloadable citations

Download HTML citationHTML Download BIB citationBIB Download RIS citationRIS
Last updated: 10 August 2022
Was this page helpful?